MARY SCHMITZ: Open Payments
NPI 1639764145 · LITCHFIELD PARK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,331 in 60 payments from 14 companies in 2025. Trend: 2023 $446 · 2024 $446 · 2025 $1,331
Food & beverage: $1,263Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $422 |
| Dendreon Pharmaceuticals LLC | 20 | $262 |
| Endo USA, Inc. | 8 | $152 |
| Sumitomo Pharma America, Inc. | 3 | $80 |
| Ferring Pharmaceuticals Inc. | 3 | $76 |
| 180 Medical, Inc. | 3 | $59 |
| Calyxo, Inc. | 1 | $52 |
| PFIZER INC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
Products named: ERLEADA, PROVENGE, RYBREVANT, AVEED, ADSTILADRIN, ORGOVYX, CVAC ASPIRATION SYSTEM, XTANDI.
Industry payments across AZ — which companies pay providers there.
